ECM
RMD icon

Evergreen Capital Management’s ResMed RMD Stock Holding History

Evergreen Capital Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$872K Buy
4,477
+1,538
+52% +$319K 0.02% 605
2026
Q1 		$660K Sell
2,939
-39
-1% -$9.72K 0.01% 638
2025
Q4 		$717K Buy
2,978
+1,274
+75% +$326K 0.02% 567
2025
Q3 		$466K Sell
1,704
-41
-2% -$11.2K 0.01% 697
2025
Q2 		$450K Buy
1,745
+118
+7% +$28.1K 0.01% 607
2025
Q1 		$364K Buy
1,627
+393
+32% +$91.7K 0.01% 644
2024
Q4 		$282K Sell
1,234
-1
-0.1% -$241 0.01% 767
2024
Q3 		$301K Sell
1,235
-167
-12% -$37.3K 0.01% 712
2024
Q2 		$268K Buy
1,402
+378
+37% +$76.7K 0.01% 704
2024
Q1 		$203K Buy
+1,024
New +$188K 0.01% 797
2023
Q4 		– Sell
-1,507
Closed -$223K – 890
2023
Q3 		$223K Buy
+1,507
New +$272K 0.01% 665

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Evergreen Capital Management's RMD Position: Q2 2026 in Review

Evergreen Capital Management increased its ResMed (RMD) stake by 52% in Q2 2026, buying an estimated $319K and bringing the position to 4,477 shares worth $872K. The position accounts for 0.02% of the portfolio, ranked #605.

Evergreen Capital Management first reported a position in RMD in Q3 2023 and has held it in 11 quarters since. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Evergreen Capital Management held 4,477 shares of ResMed worth $872K as of Q2 2026.
  • Evergreen Capital Management bought 1,538 ResMed shares in Q2 2026, an estimated $319K.
  • ResMed made up 0.02% of Evergreen Capital Management's portfolio in Q2 2026, its #605 holding.
  • Evergreen Capital Management first reported a position in ResMed in Q3 2023 and has held it in 11 quarters since.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Evergreen Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.